IDO1 and hepatocellular carcinoma: Using H22 HCC-bearing mice, we found that H2S restricted tumor growth and exhibited immunotherapeutic efficacy by downregulating IDO1 expression, inducing T-effector cells, and inhibiting MDSCs.